Chineseinvestors.com Inc. (fka CIIX)

[NetworkNewsWire]

SeeThruEquity Issues Update on CIIX

SeeThruEquity has updated its coverage and maintained its price target of $3.75 on shares of ChineseInvestors.com, Inc.’s (OTCQB: CIIX) stock. Among other highlights, the analyst noted the company’s recently released financial results for the full year fiscal 2017. The company reported revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments. The analyst also noted the company’s firm focus on the emerging cannabidiol (CBD) health products market. CIIX has high expectations for its wholly owned foreign subsidiary CBD Biotechnology Co. Ltd.’s new “CBD Magic Hemp” skin care line. CBD Biotechnology recently completed the record filing process with the China Food & Drug Administration for its first line of hemp-infused skin care products.

For more information, visit www.ChineseInvestors.com

About ChineseInvestors.com, Inc.

ChineseInvestors.com, Inc., (CIIX), headquartered in Los Angeles, with offices in New York City and Shanghai China, is a company that engages in providing a wide range of products, services, and information for the global Chinese speaking population. Founded in 1999, CIIX endeavors to be an innovative company providing (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) support services to various partners; (c) consultative services to smaller private companies considering becoming a public company; (d) advertising and public relation related support services; and (e) other services it may identify having the potential to create value or partnership opportunity with existing services.